DAFTAR PUSTAKA

Broncel M, Gorzelak-Pabis P, Sahebkar A, et al. Sleep changes following statin therapy: a

systematic review and meta-analysis of randomized placebo-controlled polysomnographic
trials. Arch Med Sci. 2015;11(5):915-926. doi:10.5114/aoms.2015.54841

Cham S, Koslik HJ, Golomb BA. Mood, personality, and behavior changes during treatment with
statins: A case series. Drug Saf - Case Reports. 2016;3(1):1-13. doi:10.1007/s40800-015-
0024-2

Fedacko, J., Singh, R., Chaithiraphan, S., Vargova, V., Tomlinson, B., De Meester, F.,
Gvozdjakova, A. and Moesgaard, S. (2010). Clinical Manifestations of Adverse Effects of
Statins, Oxidative Stress and Possible Role of Antioxidants in Prevention?~!2009-12-
25~!2010-01-11~!2010-04-22~!. The Open Nutraceuticals Journal, 3(3), pp.154-165.

Finegold JA, Manisty CH, Goldacre B, et al.(2014)The side effects of statins and other
stories.BMJ, 348(apr09 1), pp.g2574-g2574.

Gluba-Brzozka, A., Franczyk, B., Toth, P., Rysz, J. and Banach, M. (2016). Molecular
mechanisms of statin intolerance. Archives of Medical Science, 3, pp.645-658.

Golomb, B., Criqui, M., White, H. and Dimsdale, J. (2004). The UCSD Statin Study: a randomized
controlled trial assessing the impact of statins on selected noncardiac outcomes. Controlled
Clinical Trials, 25(2), pp.178-202.

Golomb BA, Evans MA. Statin adverse effects : a review of the literature and evidence for a
mitochondrial mechanism. Am J Cardiovasc Drugs. (2008);8(6):373-418.
doi:10.2165/0129784-200808060-00004

Golomb, B., Dimsdale, J., Koslik, H., Evans, M., Lu, X., Rossi, S., Mills, P., White, H. and Criqui,
M. (2015). Statin Effects on Aggression: Results from the UCSD Statin Study, a
Randomized Control Trial. PLOS ONE, 10(7), p.e0124451.

Gorzelak-Pabis, P., Durma, A., Trambowicz, K., Pypec, A., Lis, E., Rozmarynowska, I., Jurzak,
N., Ignaczak, M. and Broncel, M. (2017). The association between atorvastatin and
rosuvastatin use and sleep disturbance. Atherosclerosis, 263, p.e238.

Gupta, A., Thompson, D., Whitehouse, A., Collier, T., Dahlof, B., Poulter, N., Collins, R. and
Sever, P. (2017). Adverse events associated with unblinded, but not with blinded, statin
therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm
(ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised
non-blind extension phase. The Lancet, 389(10088), pp.2473-2481.

Hawkes, N. (2015). Results of investigation into statin side effects due by end of year. BMJ,
350(feb17 15), pp.957-957.
Jacob, K. Swiger, MD, Raoul J. Manalac, MD, Michael J. Blaha, MD, MPH, Roger S.
Blumenthal, MD. (2015). Statins, Mood, Sleep, and Physical Function: A Systematic
Review. 70(12), pp.1413–1422

Joyeux-Faure, M., Tamisier, R., Baguet, J., Dias-Domingos, S., Perrig, S., Leftheriotis, G.,
Janssens, J., Trzepizur, W., Launois, S., Stanke-Labesque, F., Lévy, P., Gagnadoux, F. and
Pepin, J. (2014). Response to Statin Therapy in Obstructive Sleep Apnea Syndrome: A
Multicenter Randomized Controlled Trial. Mediators of Inflammation, 2014, pp.1-10.

Mansi, I., Frei, C., Pugh, M. and Mortensen, E. (2013). Psychologic Disorders and Statin Use: A
Propensity Score-Matched Analysis. Pharmacotherapy: The Journal of Human
Pharmacology and Drug Therapy, 33(6), pp.615-626.

Mungall, M. and Gaw, A. (2004). Statin therapy in the elderly. Current Opinion in Lipidology,
15(4), pp.453-457.

Perwitasari, Dyah Aryani and Anni, Anni and Labado, R.O. and Udu, W.S.A. (2009) Safety
Evaluation Of Statin in Yogyakarta, Indonesia, INDONESIA. International Journal of
Pharmacy and Pharmaceutical Science, 1 (1). pp. 230-236. ISSN 0975 – 1491.

Phan, T., McLeod, J., Pollard, J., Peiris, O., Rohan, A. and Halpern, J. (1995). Peripheral
neuropathy associated with simvastatin. Journal of Neurology, Neurosurgery & Psychiatry,
58(5), pp.625-628.

Ramli, A., Aljunid, S., Sulong, S. and Md Yusof, F. (2013). National Drug Formulary review of
statin therapeutic group using the multiattribute scoring tool. Therapeutics and Clinical Risk
Management, p.491.

Reith, C., Blackwell, L., Emberson, J., Mihaylova, B., Armitage, J., Fulcher, J., Keech, A., Simes,
J., Baigent, C. and Collins, R. (2016). Protocol for analyses of adverse event data from
randomized controlled trials of statin therapy. American Heart Journal, 176, pp.63-69.

Takada, M., Fujimoto, M., Yamazaki, K., Takamoto, M. and Hosomi, K. (2014). Association of
Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and
a Prescription Database. Drug Safety, 37(6), pp.421-431.

Thompson, P., Gregory Panza, Amanda Zaleski, and Beth Taylor. (2016). What to Believe and
Do About Statin-Associated Adverse Effects. JAMA, 316(19), p.1969.

Tuccori, M., Montagnani, S., Mantarro, S., Capogrosso-Sansone, A., Ruggiero, E., Saporiti, A.,
Antonioli, L., Fornai, M. and Blandizzi, C. (2014). Neuropsychiatric Adverse Events
Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management.
CNS Drugs, 28(3), pp.249-272.

Van Gastel, A. (2018). Drug-Induced Insomnia and Excessive Sleepiness. Sleep Medicine Clinics,
13(2), pp.147-159.
Wise, J. (2017). Breast screening benefits have been overstated, Danish study finds. BMJ, p.j94.

Ziegenbein, M., Held, K., Kuenzel, H., Murck, H., Antonijevic, I. and Steiger, A. (2003). The
Somatostatin Analogue Octreotide Impairs Sleep and Decreases EEG Sigma Power in
Young Male Subjects. Neuropsychopharmacology, 29(1), pp.146-151.